Main > ONCOLOGY (**) > Gastric Cancer>HER2-,CLDN18.2+> > >UnResectable; MET/R> > JP. A. Treat.>CLDN18.2 MAb+CT

---

JP. A. Treat.>CLDN18.2 MAb+CT's subsections
(*) JP Approval Date: 2024. 03.26
Company
Generic Name
Patent>JP Patent Numbers
Patent>USA Patent Numbers
PR Web-Site
TM

JP. A. Treat.>CLDN18.2 MAb+CT's products
This section has no products